Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$30.21 - $48.1 $28,639 - $45,598
-948 Reduced 3.75%
24,305 $808,000
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $863,652 - $1.31 Million
25,253 New
25,253 $864,000
Q1 2022

May 13, 2022

SELL
$27.77 - $64.4 $746,346 - $1.73 Million
-26,876 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$54.9 - $105.21 $355,806 - $681,866
6,481 Added 31.78%
26,876 $1.69 Million
Q3 2021

Nov 12, 2021

SELL
$105.0 - $178.37 $619,290 - $1.05 Million
-5,898 Reduced 22.43%
20,395 $2.15 Million
Q2 2021

Aug 12, 2021

BUY
$125.11 - $180.0 $3.29 Million - $4.73 Million
26,293 New
26,293 $4.65 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.59B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.